Fullerene (C 60 )-based tumor-targeting nanoparticles with “off-on” state for enhanced treatment of cancer
Authors:
- 1 August 2016
- journal article
- retracted article
- Published by Elsevier in Journal of Controlled Release
- Vol. 235, 245-258
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81273451, 81302717, 81101684)
- China Postdoctoral Science Foundation (2015M582210)
This publication has 30 references indexed in Scilit:
- Photochemical internalization (PCI) of immunotoxins targeting CD133 is specific and highly potent at femtomolar levels in cells with cancer stem cell propertiesJournal of Controlled Release, 2013
- In vivo tumor targeting by a NGR-decorated micelle of a recombinant diblock copolypeptideJournal of Controlled Release, 2011
- Cell-Specific, Activatable, and Theranostic Prodrug for Dual-Targeted Cancer Imaging and TherapyJournal of the American Chemical Society, 2011
- Fullerene C60 as a multifunctional system for drug and gene deliveryNanoscale, 2011
- Superparamagnetic Iron Oxide Nanotheranostics for Targeted Cancer Cell Imaging and pH-Dependent Intracellular Drug ReleaseMolecular Pharmaceutics, 2010
- Bioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrierBiomaterials, 2010
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60)Biomaterials, 2008
- Aminopeptidase N/CD13 targeting fluorescent probes: Synthesis and application to tumor cell imagingPeptides, 2005
- pH-Responsive Copolymer Assemblies for Controlled Release of DoxorubicinBioconjugate Chemistry, 2005